These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6704197)
1. Colchicine inhibition of serum amyloid protein SAA and SAP synthesis in primary mouse liver cell cultures. Tatsuta E; Sipe JD; Shirahama T; Skinner M; Cohen AS Arthritis Rheum; 1984 Mar; 27(3):349-52. PubMed ID: 6704197 [No Abstract] [Full Text] [Related]
2. Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response. Brandwein SR; Sipe JD; Tatsuta E; Skinner M; Cohen AS J Rheumatol; 1984 Oct; 11(5):597-601. PubMed ID: 6334740 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. Benson MD; Kleiner E J Immunol; 1980 Feb; 124(2):495-9. PubMed ID: 6985931 [No Abstract] [Full Text] [Related]
4. Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Selinger MJ; McAdam KP; Kaplan MM; Sipe JD; Vogel SN; Rosenstreich DL Nature; 1980 Jun; 285(5765):498-500. PubMed ID: 7402294 [TBL] [Abstract][Full Text] [Related]
5. Different regulatory mechanisms for serum amyloid A and serum amyloid P synthesis by cultured mouse hepatocytes. Tatsuta E; Sipe JD; Shirahama T; Skinner M; Cohen AS J Biol Chem; 1983 May; 258(9):5414-8. PubMed ID: 6853523 [TBL] [Abstract][Full Text] [Related]
6. In vitro synthesis of the acute phase reactant SAA by hepatocytes. Benson MD Ann N Y Acad Sci; 1982; 389():116-20. PubMed ID: 6953914 [No Abstract] [Full Text] [Related]
7. The role of interleukin 1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Sipe JD; Vogel SN; Sztein MB; Skinner M; Cohen AS Ann N Y Acad Sci; 1982; 389():137-50. PubMed ID: 6807177 [TBL] [Abstract][Full Text] [Related]
8. Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains. Zahedi K; Gonnerman WA; Debeer FC; Debeer MC; Steel DM; Sipe JD; Whitehead AS Inflammation; 1991 Feb; 15(1):1-14. PubMed ID: 1711511 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructural evidence for the synthesis of serum amyloid A protein by murine hepatocytes. Takahashi M; Yokota T; Yamashita Y; Ishihara T; Uchino F Lab Invest; 1985 Feb; 52(2):220-3. PubMed ID: 3881624 [TBL] [Abstract][Full Text] [Related]
10. In vitro induction of hepatocyte synthesis of the acute phase reactant mouse serum amyloid P-component by macrophages and IL 1. Le PT; Mortensen RF J Leukoc Biol; 1984 Jun; 35(6):587-603. PubMed ID: 6610015 [TBL] [Abstract][Full Text] [Related]
11. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288 [TBL] [Abstract][Full Text] [Related]
12. Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse. Baltz ML; Dyck RF; Pepys MB Clin Exp Immunol; 1985 Jan; 59(1):235-42. PubMed ID: 3882285 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous participation of the hepatocyte population in amyloid protein AA synthesis. Shirahama T; Skinner M; Cohen AS Cell Biol Int Rep; 1984 Oct; 8(10):849-56. PubMed ID: 6509560 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy. Kisilevsky R; Boudreau L; Foster D Lab Invest; 1983 Jan; 48(1):60-7. PubMed ID: 6823092 [TBL] [Abstract][Full Text] [Related]
15. Induction and regulation by monokines of hepatic synthesis of the mouse serum amyloid P-component (SAP). Le PT; Mortensen RF J Immunol; 1986 Apr; 136(7):2526-33. PubMed ID: 3512716 [TBL] [Abstract][Full Text] [Related]
16. The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition. Kisilevsky R; Benson MD; Axelrad MA; Boudreau L Lab Invest; 1979 Sep; 41(3):206-10. PubMed ID: 470340 [TBL] [Abstract][Full Text] [Related]
17. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains. Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist. Grehan S; Herbert J; Whitehead AS Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615 [TBL] [Abstract][Full Text] [Related]
19. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation. Zahedi K; Whitehead AS J Immunol; 1989 Nov; 143(9):2880-6. PubMed ID: 2809211 [TBL] [Abstract][Full Text] [Related]
20. An in vitro cellular system for generation of AA-amyloid. Palm M; Nielsen EH; Svehag SE APMIS; 1997 Aug; 105(8):603-8. PubMed ID: 9298097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]